Skip to content
★ Sign in to follow
JB

Jiangsu Bioperfectus Technologies Co., Ltd. Stock: price and insider trades · China

硕世生物

CN·Mcap CN¥2.9BHealth Care

Jiangsu Bioperfectus Technologies Co., Ltd.: what insiders have been doing

Jiangsu Bioperfectus Technologies Co., Ltd. has a thin disclosure history in our data (latest filing: 15 June 2021). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€832,796
1 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,434 of 26,911 companies
30.9
score / 100
Value
30
Quality
32
FCF yld-1.2%
Earn yld-1.4%
EV/EBITDA·
ROE-0.8%
Gross mgn63%
Net mgn-12%
Debt/EBITDA11.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥23.39
Analyst consensus
·
Income statement
RevenueCN¥339M
Gross profitCN¥214.1M63% margin
EBITDACN¥32.9M10% margin
Net income-CN¥41.1M-8.2% margin
Valuation
P/Book1.0x
Beta0.75
Balance sheet & cash
Market capCN¥2.9B
Total debtCN¥377.1M
Free Cash Flow-CN¥34.1M
Debt / Equity19%
Profitability & ownership
ROE-0.8%
ROA-1.0%
% insiders46.6%
% institutions0.9%
Last declaration on 15 June 2021
Declarations1 total
  • ▼
    监事Executives
    6M CNY15SSE
    40,200 shares100.0% of flowA股XSHGSSE:173000004486689400

1 of 1 declaration

About Jiangsu Bioperfectus Technologies Co., Ltd.

硕世生物 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on developing innovative biopharmaceutical solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations